ReNeuron Group
RENE:LN
Latest Coverage
article
ReNeuron Group plc - Capital Markets Event and Webcast
30 Apr 2018
article
ReNeuron Group plc - Wins grant for retinal cell therapy development
19 Apr 2018
article
ReNeuron Group plc - Appointment of US-based Chief Medical Officer
10 Apr 2018
article
ReNeuron Group plc - Preliminary Results
29 Jun 2017
Company Profile
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Classification
SectorHealthcare
IndustryNot yet available
SubindustryNot yet available
Financials
Financial data is not yet available for this company.
Financials Data
Financial data is not yet available for this company.